{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-9960.2",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 9960.2 - Process for allowing coverage of excluded drugs",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 9960.2 - Process for allowing coverage of excluded drugs\n\nState Regulations\n(a) Request for coverage. (1)\n\nAny drug package, or form of dosage or\nadministration excluded from coverage as a benefit under EPIC pursuant to\nsection\n9960.3\nof this Part may be allowed to be dispensed to a specific eligible participant\nbased upon a written request for coverage by a licensed physician and a legal\nprescription. (2)\n\nEach request for\ncoverage shall be supported by a written certification and specific reasons why\nan excluded drug package or form of dosage or administration is considered by a\nlicensed physician to be medically indicated for treatment of a specific\npatient. (3)\n\nRequests for coverage\npursuant to paragraph (1) of this subdivision shall be made only by a licensed\nphysician treating an eligible participant for whom such excluded drug benefit\nis considered to be medically indicated. (4)\n\nAll requests for coverage of an excluded\ndrug benefit shall be supported by information submitted by a physician on a\n\nDrug Application Information form and submitted to the department. Telephone\nrequests may be made to the department; however, all such telephone requests\nfor information shall be followed by submission of the required information on\na completed Drug Application Information form to facilitate proper review and\ndisposition of each request. (b) Drug Application Information form. (1)\n\nInformation to support a certification by\na licensed physician as to the medical indication for treating an eligible\nparticipant with a drug considered to be an excluded drug shall be contained on\na Drug Application Information form. Such information shall include the\nfollowing: (i) name of drug, dosage form, strength and name of marketer; (ii)\nname and identification number of participant; (iii)\nlength of time physician has treated\nthe participant; (iv)\nname of\nillness/disease/condition being treated; (v) length of time participant has been\ntaking the drug requested; (vi)\nlist of other medications used to treat the participant; (vii)\nspecific reasons why requested drug is\nmedically indicated; (viii)\nmedical\nconsequences if excluded drug is not provided as a covered drug\nbenefit; (ix)\nidentification and\nsignature of the licensed physician treating the participant. (2)\n\nCopies of the Drug Application\n\nInformation form shall be made available by the department, or from local\ncounty offices for the aging or health departments, or the EPIC executive\ndirector or EPIC contractor. (c) Decisions on coverage. (1)\n\nUpon receipt of a completed Drug\n\nApplication Information form submitted by a licensed physician, the department\nshall review the request and render a decision within three working days. Failure to render a decision within this time period shall not constitute\napproval by the department. (2)\n\nWritten notice of the decision shall be sent by the department to the licensed\nphysician who requested coverage of an excluded drug for a particular eligible\nparticipant within seven working days following such decision. Similar written\nnotice shall also be provided to the EPIC contractor by the EPIC executive\ndirector and to the participant to inform such person of this individual rights\nto be reimbursed for an excluded drug which is determined to be included as a\ncovered benefit. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\nยง\n9960.2\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 60765
}